Bioera S.p.A. (BIE.MI)

EUR 0.04

(0.0%)

Operating Income Summary of Bioera S.p.A.

Bioera S.p.A.'s latest annual operating income in 2023 was -3.36 Million EUR , up 6.57% from previous year.
Bioera S.p.A.'s latest quarterly operating income in 2024 Q2 was -1.07 Million EUR , up 37.54% from previous quarter.
Bioera S.p.A. reported an annual operating income of -3.6 Million EUR in 2022, down -122.69% from previous year.
Bioera S.p.A. reported an annual operating income of 15.89 Million EUR in 2021, up 361.95% from previous year.
Bioera S.p.A. reported a quarterly operating income of -1.72 Million EUR for 2023 Q4, down -153.08% from previous quarter.
Bioera S.p.A. reported a quarterly operating income of -682 Thousand EUR for 2023 Q2, up 75.04% from previous quarter.

Annual Operating Income Chart of Bioera S.p.A. (2023 - 2005)

Historical Annual Operating Income of Bioera S.p.A. (2023 - 2005)

Year	Operating Income	Operating Income Growth
2023	-3.36 Million EUR	6.57%
2022	-3.6 Million EUR	-122.69%
2021	15.89 Million EUR	361.95%
2020	-6.06 Million EUR	-23.12%
2019	-4.92 Million EUR	-162.63%
2018	-1.87 Million EUR	56.29%
2017	-4.29 Million EUR	-176.72%
2016	-1.55 Million EUR	-6.74%
2015	-1.45 Million EUR	2.35%
2014	-1.48 Million EUR	-1098.66%
2013	149 Thousand EUR	-95.44%
2012	3.26 Million EUR	-60.46%
2011	8.26 Million EUR	1793.24%
2010	-488 Thousand EUR	74.52%
2009	-1.91 Million EUR	-184.14%
2008	2.27 Million EUR	-43.38%
2007	4.02 Million EUR	-3.3%
2006	4.15 Million EUR	-4.74%
2005	4.36 Million EUR	0.0%

Year	Operating Income	Operating Income Growth
2024 Q2	-1.07 Million EUR	37.54%
2023 Q4	-1.72 Million EUR	-153.08%
2023 Q2	-682 Thousand EUR	75.04%
2023 FY	-3.36 Million EUR	6.57%
2022 Q4	-2.73 Million EUR	-193.13%
2022 FY	-3.6 Million EUR	-122.69%
2022 Q2	-932 Thousand EUR	42.54%
2021 Q2	-1.35 Million EUR	70.87%
2021 FY	15.89 Million EUR	361.95%
2021 Q4	-1.62 Million EUR	-20.15%
2020 Q2	-2.7 Million EUR	40.48%
2020 FY	-6.06 Million EUR	-23.12%
2020 Q4	-4.63 Million EUR	-71.25%
2019 FY	-4.92 Million EUR	-162.63%
2019 Q4	-4.54 Million EUR	-102.13%
2019 Q2	-2.24 Million EUR	-165.21%
2018 Q4	-848 Thousand EUR	27.21%
2018 Q2	-1.16 Million EUR	44.44%
2018 FY	-1.87 Million EUR	56.29%
2017 Q4	-2.09 Million EUR	-41.4%
2017 FY	-4.29 Million EUR	-176.72%
2017 Q2	-1.48 Million EUR	-3.63%
2016 Q4	-1.43 Million EUR	-23750.0%
2016 FY	-1.55 Million EUR	-6.74%
2016 Q2	-6000.00 EUR	99.06%
2015 Q2	-699 Thousand EUR	40.81%
2015 Q4	-639 Thousand EUR	8.58%
2015 FY	-1.45 Million EUR	2.35%
2014 Q4	-1.18 Million EUR	-236.47%
2014 Q2	-351 Thousand EUR	58.9%
2014 FY	-1.48 Million EUR	-1098.66%
2013 Q2	112 Thousand EUR	0.0%
2013 FY	149 Thousand EUR	-95.44%
2013 Q4	-854 Thousand EUR	-862.5%
2012 FY	3.26 Million EUR	-60.46%
2011 FY	8.26 Million EUR	1793.24%
2011 Q2	- EUR	0.0%
2010 Q2	- EUR	0.0%
2010 FY	-488 Thousand EUR	74.52%
2009 Q2	- EUR	0.0%
2009 FY	-1.91 Million EUR	-184.14%
2008 FY	2.27 Million EUR	-43.38%
2007 FY	4.02 Million EUR	-3.3%
2006 FY	4.15 Million EUR	-4.74%
2005 FY	4.36 Million EUR	0.0%

Peer Operating Income Comparison of Bioera S.p.A.

Name	Operating Income	Operating Income Difference
GPI S.p.A.	27.78 Million EUR	112.121%
Poste Italiane S.p.A.	3.05 Billion EUR	100.11%